The famous US tech investor Cathie Wood is making bold moves in the AI space, investing $11 million into Beam Therapeutics, an AI-driven genetic medicine firm. Despite past underperformance, Ark Innovation ETF (ARKK) is rebounding in 2025, outperforming major indices. With Trump-era deregulation boosting sentiment and AI's growing role in biotech, Ark's strategy could see a resurgence.